Cuba to host First Regional Scientific Conference on Diabetes

Today there are more than 366 million people affected with this condition that kills 4.6 million people annually, which represents a challenge for health systems worldwide, according to WHO statistics.

World Diabetes Day (WDD) is celebrated every year on November 14. The World Diabetes Day campaign is led by the International Diabetes Federation (IDF) and its member associations. It engages millions of people worldwide in diabetes advocacy and awareness. World Diabetes Day was created in 1991 by the IDF and the World Health Organization (WHO) in response to growing concerns about the escalating health threat that diabetes now poses. World Diabetes Day became an official United Nations Day in 2007 with the passage of United Nation Resolution 61/225. The campaign draws attention to issues of paramount importance to the diabetes world and keeps diabetes firmly in the public spotlight. 

World Diabetes Day is a campaign that features a new theme chosen by the International Diabetes Federation each year to address issues facing the global diabetes community. While the themed campaigns last the whole year, the day itself is celebrated on November 14, to mark the birthday of Frederick Banting who, along with Charles Best, first conceived the idea which led to the discovery of insulin in 1922.

Diabetes Education and Prevention is the World Diabetes Day theme for the period 2009-2013.

As part of activities for World Diabetes Day, 2013,  the provinces of Artemisa and Mayabeque will host the First Regional Scientific Conference on the disease.

According to Mailyn Palmero, promoter of Heberprot-P, the new and unique Cuban medicine for diabetic foot ulcers, the Provincial Health Director and political and mass organizations of Bauta town will sponsor the conference which will be held from November 11 to 14,.  Heberprot-P is patented in 19 countries.

The scientific sessions, dedicated this year to the management of patients with diabetic foot ulcers and to the treatment of patients using the Cuban medical product Heberprot-P, will contribute to the improvement of the quality of care and the administration of the drug to people with this affection in the western territory, said Palmero.

These include active investigations leading to the diagnosis of the disease and its complications, educational lectures by health professionals and meetings with the leading researcher of Heberprot-P, Jorge Berlanga PhD., from the Center for Genetic Engineering and Biotechnology.

Also to be developed are posters and brochures campaigns, informational meetings about diabetic foot ulcers and its novel treatment as an alternative to amputation.

Today there are more than 366 million people affected with this condition that kills 4.6 million people annually, which represents a challenge for health systems worldwide, according to WHO statistics.

Related article:

• Dr. Fuhrman: 6 Worst Foods for Diabetes
• Dr. Fuhrman: The Best Way to Prevent and Reverse Type 2 Diabetes
  
  • Thousands Avoid Foot Amputation Thanks to New Cuban Medicine
  • Ecuador Will Treat Foot Ulcers in Diabetic Patients with Cuba’s Heberprot-P
  • More Countries Show Interest in Cuban Medicine for Diabetic Patients